Alpha 2.0
Login Register
» Articles » PMID: 35487679

Correspondence on 'No Efficacy of Anti-IL-23 Therapy for Axial Spondyloarthritis in Randomised Controlled Trials but in Post-hoc Analyses of Psoriatic Arthritis-related 'physician-reported Spondylitis'?'

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 2022 Apr 29
PMID 35487679
Authors
Dafna D Gladman
Philip J Mease
Paul Bird
Enrique R Soriano
Soumya D Chakravarty
May Shawi
Frederic Lavie
Cinty Gong
Evan Leibowitz
Denis Poddubnyy
Lai-Shan Tam
Philip S Helliwell
Arthur Kavanaugh
Atul A Deodhar
Mikkel Ostergaard
Xenofon Baraliakos
Affiliations
Soon will be listed here.
Citing Articles

BASDAI versus ASDAS in evaluating axial involvement in patients with psoriatic arthritis: a pooled analysis of two phase 3 studies.

Baraliakos X, Gladman D, Chakravarty S, Gong C, Shawi M, Rampakakis E Rheumatol Adv Pract. 2024; 8(2):rkae058.

PMID: 38765190 PMC: 11099656. DOI: 10.1093/rap/rkae058.

Same, same or different? Commonalities and differences between spondyloarthritis and its subsets of axial and peripheral spondyloarthritis with psoriatic arthritis and its diverse phenotypes.

Proft F, Kading H RMD Open. 2023; 9(2).

PMID: 37028815 PMC: 10083843. DOI: 10.1136/rmdopen-2022-002872.

Comparison of patients with axial PsA and patients with axSpA and concomitant psoriasis: an analysis of the German register RABBIT-SpA.

Regierer A, Weiss A, Proft F, Baraliakos X, Behrens F, Poddubnyy D RMD Open. 2023; 9(1).

PMID: 36898762 PMC: 10008170. DOI: 10.1136/rmdopen-2022-002837.